We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$51.1M
Cap. Flow
-$26M
Cap. Flow %
-1.33%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$10.1M

Top Sells

Rank Stock Value
1
QXO
QXO Inc
QXO
+$167M
2
SLDB icon
Solid Biosciences
SLDB
+$5.42M

Sector Composition

Rank Sector Weight
1 Industrials 21.33%
2 Energy 0.01%
3 Healthcare 0%

No holdings matched the selected filter criteria.

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Finepoint Capital held 11 positions worth $1.95B, down 2.6% from $2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Finepoint Capital's Q1 2026 filing shows 2 new, 1 increased, 2 reduced and 2 closed positions. The largest sale was QXO Inc, an estimated $167M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 26% a quarter earlier, followed by Energy and Healthcare.

  • Finepoint Capital added most to RXO in Q1 2026, an estimated $10.1M increase.
  • Finepoint Capital's biggest Q1 2026 reduction was QXO Inc, cutting an estimated $167M.
  • Finepoint Capital fully exited Solid Biosciences in Q1 2026, selling an estimated $5.42M.
  • Finepoint Capital's ten largest holdings make up 100% of its $1.95B portfolio in Q1 2026.
  • Finepoint Capital opened 2 new positions and closed 2 in Q1 2026.
  • Finepoint Capital's portfolio value fell 2.6% quarter-over-quarter to $1.95B.

Based on Finepoint Capital's 13F filing for Q1 2026, filed 14 May 2026.